Journal of Leukocyte Biology Accuri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bülow, E.
Right arrow Articles by Olsson, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bülow, E.
Right arrow Articles by Olsson, I.
(Journal of Leukocyte Biology. 2002;72:147-153.)
© 2002 by Society for Leukocyte Biology

Sorting of neutrophil-specific granule protein human cathelicidin, hCAP-18, when constitutively expressed in myeloid cells

Elinor Bülow*, Niklas Bengtsson*, Jero Calafat{dagger}, Urban Gullberg* and Inge Olsson*

* Department of Hematology, Lund University, Sweden; and
{dagger} The Netherlands Cancer Institute, Amsterdam

Correspondence: Elinor Bülow, Dept. of Hematology, BMC, C14, S-221 84 Lund, Sweden. E-mail: elinor.bulow{at}hematologi.lu.se


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Neutrophil granulocytes carry storage organelles, e.g., azurophil and specific granules. Poorly understood are the mechanisms for retrieval from constitutive secretion followed by sorting for storage. Therefore, we asked whether the specific granule protein human cathelicidin (hCAP-18) could be sorted for storage in other granules when the biosynthetic window is widened to allow this. We observed that hCAP-18 was targeted for storage in lysosome-related organelles when expressed constitutively in the rat basophilic leukemia and the mouse promyelocytic (MPRO) cell lines. In addition, premature release of the antibiotic C-terminal peptide LL-37 was observed. Retention of hCAP-18 was diminished by induction of differentiation of MPRO cells. In conclusion, a specific granule protein with native conformation may be sorted for storage in lysosome-related organelles of myeloid cells and converted prematurely to a supposedly biologically active form.

Key Words: secretory pathway • storage • LL-37 • lysosome-related organelle • azurophil granule


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
During granulocytic maturation, antimicrobial proteins [1 ] and hydrolytic enzymes, critical elements of innate immunity, are being manufactured for storage in cytoplasmic granules and are released after maturation into neutrophils upon stimulation [2 ]. Consequently, as a result of biosynthesis and sorting in precursor cells, mature neutrophils will carry a load of granules, like azurophil (primary) and specific (secondary), each granule type with unique composition [3 ]. The lysosome-like azurophils are manufactured when granules start to form in promyelocytes, whereas specific granules are synthesized later, in myelocytes. Azurophil granules store myeloperoxidase (MPO) [4 ], bactericidal/permeability-increasing protein (BPI) [5 ], defensins [6 ], lysosomal hydrolases, and many catalytically active cationic serine proteases [7 ]. The latter create a potential risk for autodigestion, but are probably harmless in the condensed environment of granules. In contrast to azurophil granules, specific granules store proteins as intact proforms, e.g., matrix metalloproteases and antimicrobial proteins such as human cathelicidin (hCAP-18); their corresponding mature forms might not be stable enough for prolonged storage. hCAP-18 [8 9 10 11 ] has a large cathelin-like prosegment, highly conserved among species, connected to the sequence for the carboxy-terminal antibacterial peptide LL-37, a 37 amino acid amphiphatic helix. The cathelin-like segment is removed for release of the microbicidal activity of LL-37, whose normal generation is catalyzed by exposure to serine proteases originating from azurophil granules [12 ]. Antimicrobial LL-37 can also bind and neutralize endotoxin [8 ] and recruit, by chemotaxis, neutrophils, monocytes, and T cells, to sites of infection [13 ].

Azurophil granules are considered lysosome-like [14 ]. Although poorly understood, their biogenesis may, however, differ from that of the typical lysosome-related organelles of many other hematopoietic cells that involve transfer of vesicles from the trans Golgi network (TGN) to late endosomes, often with the appearance of multivesicular bodies, followed by mature granule formation [15 ]. In contrast, biogenesis of azurophil granules may have certain features in common with that of granules for regulated secretion in endocrine, neuroendocrine, and exocrine cells. During maturation of regulated secretory granules of the latter cells, the composition of granules is refined by removal of mistakenly sorted, soluble and membrane proteins before maturation to dense-core granules [16 ]. The production of specific granules of neutrophils has not yet been thoroughly investigated, but acidification mechanisms are important in transfer of lactoferrin for normal storage in specific granules [17 ].

The aim of this work is to investigate whether hCAP-18, a normal constituent of specific granules, can also be sorted for storage in lysosome-related organelles of myeloid cells and remain stable. Therefore, we characterize sorting and processing of hCAP-18 after expression in the rat basophilic leukemia (RBL) and the mouse promyelocytic (MPRO) cell lines. Thus, our experiments represent an attempt of mistargeting hCAP-18 for storage in lysosome-related organelles where it does not normally belong. The rationale for doing this is that many azurophil granule proteins have been expressed in RBL cells, and in other myeloid cell lines before, and were shown to be processed correctly under the same conditions used here for the hCAP-18 experiments. For instance, hematopoietic serine proteases, MPO, and BPI have been investigated extensively and have demonstrated as being targeted, processed, and stored in lysosome-related organelles of RBL cells [2 ]. The latter organelles are regarded as equivalent to azurophil granules of neutrophils, although the latter, in contrast to the RBL organelles, lack some lysosome-associated membrane proteins [18 , 19 ]. In any case, lysosome-related organelles of RBL cells should represent a rather natural environment for storage of azurophil granule proteins but not for hCAP-18. The present results may therefore shed light on mechanisms of retrieval for storage in myeloid granules, the stability of proteins in this environment, and the consequences of timing of expression of genes for granule proteins. Widening the window for biogenesis through constitutive expression in HL-60 cells of neutrophil gelatinase-associated lipocalin (NGAL), like hCAP-18, a normal constituent of specific granules, resulted in targeting to azurophil granules, followed, however, by slow degradation in this proteolytic environment [20 ]. We demonstrate that hCAP-18 can be mistargeted for storage in lysosome-related granules of RBL and MPRO cells. The antibiotic C-terminal peptide of hCAP-18 was, however, released prematurely, more strongly in RBL granules than in MPRO granules. In conclusion, our results illustrate that mistargeting specific granule proteins to lysosome-related organelles may furnish premature processing to mature forms and potential instability depending on protein conformation.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Materials
The eukaryotic expression vector pcDNA3 was from Invitrogen (Groningen, The Netherlands). [35S]Methionine/[35S]cysteine, and [14C]leucine (cell-labeling grade) were from ICN Pharmaceuticals, Inc. (Costa Mesa, CA). L-glutamine, heat-inactivated fetal calf serum (FCS), RPMI 1640, and Dulbecco’s modified Eagle’s medium (DMEM) with glutamax were from Gibco-BRL (Life Technologies, Inc., Rockville, MD). Percoll, protein A-Sepharose CL-4B, ECLTM (Western blotting detection reagents), and HybondTM ECLTM nitrocellulose membranes were from Amersham Pharmacia Biotech, UK Limited (Buckinghamshire). 2-Mercaptoethanol was from Sigma-Aldrich Co. (St. Louis, MO). Geneticin and CompleteTM (protease-inhibitor cocktail tablets) were from Roche Molecular Biochemicals (Mannheim, Germany). Novex Pre-cast gels (10–20% Tris-glycine gels and NuPAGE 10% Bis-Tris gels) were from Invitrogen (San Diego, CA). Rabbit polyclonal antiserum to hCAP-18 was a gift from Dr. J. W. Larrick (Palo Alto, CA) and Dr. O. Sørensen (Copenhagen, Denmark). Rabbit polyclonal antiserum to LL-37 was a gift from Dr. G. H. Gudmundsson (Karolinska Institute, Stockholm, Sweden). Rabbit anti-lysosomal glycoprotein 120 (lgp 120) antiserum was from Dr. I. Mellman (Yale University School of Medicine, New Haven, CT).

Construction of expression vectors
A cDNA for hCAP-18 was generously provided by Dr. Hans G. Boman (Stockholm University, Sweden) [9 ]. The pBluescript KS vector was cleaved with Pvu1 and was used as a template in a 20-cycle polymerase chain reaction to create the insert hCAP-18 containing the Kozak consensus leader sequence for maximal translational efficiency [21 ] and the flanking restriction enzyme sites for HindIII and Not1, added by the primers. The upstream primer 5'-GACTTCAGAAGCTTCCGCCACCATGAAGACCCAAAGGAATGGCCAC(primer no. 1) and downstream primer 5'-GACTTCAGGCGGCCGCCTAGGACTCTGTCCTGGGTACAAGA (primer no. 2; start and stop codons in boldface and restriction enzyme sites underlined) were used. The resulting product was cloned into the plasmid pcDNA3 to create the expression vector pcDNA3/hCAP-18.

cDNA constructs were investigated by in vitro translation, and the expected size was verified in each case.

Cell culture
The rat basophilic/mast cell line RBL-1 [22 ] was cultured as described previously [23 ]. The mouse promyelocyte cell line MPRO (MPRO.C1, monoclonal subclone) [24 ] was grown in DMEM supplemented with 7% FCS, 20% HM-5 conditioned medium as a source of granulocyte macrophage-colony stimulating factor, and 1% L-glutamine [24 , 25 ]. The HM-5 cells, kindly provided by Dr. Jack Cowland (Copenhagen, Denmark), were maintained in RPMI 1640 supplemented with 10% FCS. The conditioned medium was obtained by growing the cells to 80% confluence, changing to fresh medium, and harvesting conditioned medium after 48 h [25 ].

Transfection procedures
RBL and MPRO cells were transfected with pcDNA3 constructs using the Bio-Rad Gene PulserTM (Bio-Rad, Hercules, CA), with electrical settings of 260 V and 960 µF as described previously [26 ]. After electrophoresis, geneticin (2 and 1 mg/ml, respectively) was added to select for recombinant clones containing the geneticin resistance of pcDNA3. Individual antibiotic-resistant RBL cell clones (monoclonal) [23 ] or antibiotic-resistant MPRO cell pools (polyclonal) were selected and expanded in suspension cultures and were screened for expression of the transfected protein.

Biosynthetic radiolabeling
Biosynthetic radiolabeling of the newly synthesized proteins by stably transfected cell lines was carried out as described previously [26 ]. Cells were starved for 30 min followed by incubation with [35S]methionine/[35S]cysteine or [14C]leucine (pulse-labeling). For chase of the radiolabeled proteins, the cells were resuspended in complete nonradioactive medium after radiolabeling. At various time intervals, cells were withdrawn and subjected to analysis.

Subcellular fractionation
Subcellular fractionation was performed as described [26 ]. Thus, the postnuclear cell homogenate was centrifuged in a Percoll density gradient followed by collection of nine fractions, fraction 9 containing the cytosol. The distribution of lysosome-related organelles and Golgi elements in the gradient was determined by assaying ß-hexosaminidase and galactosyl transferase as described elsewhere [27 , 28 ]. The peak activities of ß-hexosaminidase and galactosyl transferase in subcellular fractions from RBL cells were localized in fractions 1–2 (containing the dense cytoplasmic organelles referred to in this work) and 5–8, respectively [23 ].

Immunoprecipitation
Immunoprecipitation was performed as described previously [29 ].

Western blotting
The enhanced chemiluminescence Western blotting kit was used according to the manufacturer’s instructions. Briefly, 5 x 106 cells were washed once in phosphate-buffered saline and were then frozen at -80°C for at least 20 min. The cell pellet was diluted in 100 µl lysis buffer [86 mM Tris (pH 6.8), 11% (v/v) glycerol, 2.3% (w/v) sodium dodecyl sulfate (SDS), 1.2% (v/v) ß-mercaptoethanol, 0.005% (v/v) bromphenol blue] containing protease inhibitors (CompleteTM), after which the cells were lysed by sonication for ~10 s with a Dr. Hielsher sonicator (B. Braun Biotech International, Melsungen, Germany). Samples were boiled for 5 min and collected by centrifugation at 14,000 g at 4°C for 5 min. A lysate from 0.5 x 106 cells was loaded in each lane of a precast 10–20% Tris-glycine gel. Proteins were transferred electrophoretically to Hybond-P nitrocellulose membrane in blotting buffer. Detection was performed according to the manufacturer’s instructions, and the membranes were exposed to HyperfilmTM ECLTM for 60 s.

Immunoelectron microscopy
RBL cells stably transfected with hCAP-18 were fixed for 24 h in 4% paraformaldehyde in 0.1 M PHEM (PIPES-HEPES-EGTA-Mg2+) buffer (pH 6.9) and were then processed for ultrathin cryosectioning as described before [30 ]. Cryosections (45 nm) were cut at -125°C using diamond knives (Drukker Cuijk, The Netherlands) in an ultracryomicrotome (Leica Aktiengesellschaft, Vienna, Austria) and were transferred with a mixture of sucrose and methyl cellulose onto formvar-coated copper grids [31 ]. The grids were placed on 35-mm petri dishes containing 2% gelatin. Double-immunolabeling was performed using a previously described procedure [32 ] with 10- and 15-nm protein-A-conjugated colloidal gold probes (EM Lab., Utrecht University, The Netherlands). After immunolabeling, the cryosections were embedded in a mixture of methylcellulose and uranyl acetate and examined with a Philips CM 10 electron microscope (Eindhoven, The Netherlands). For the controls, the primary antibody was replaced by a nonrelevant rabbit antiserum.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Expression of hCAP-18 in RBL and MPRO cells
hCAP-18 is normally stored unprocessed as an 18-kDa protein in specific granules of neutrophils and is processed after degranulation [33 ]. The processing of hCAP-18 was investigated in RBL and MPRO cells, stably transfected with hCAP-18 cDNA. Pulse-chase-radiolabeling experiments with radioactive methionine/cysteine were performed. Immunoprecipitation visualized 18-kDa hCAP-18 and a presumed 17-kDa proform [33 ] that was prominent early after radiolabeling (Fig. 1A ). After chase of the label, two processing forms of 15 and 16 kDa appeared and increased concomitantly with a decrease of hCAP-18. The processing forms diminished with prolonged chase of the label (data not shown). Only hCAP-18 was secreted during chase (Fig. 1A) . The immunoprecipitations for experiments of Figure 1A were performed with an antibody to hCAP-18 that does not recognize the antibiotic peptide LL-37 if it were released from hCAP-18 (see below). Therefore, similar experiments were performed with an antibody to LL-37 where radioactive leucine was used for radiolabeling instead of methionine/cysteine, as LL-37 does not contain the latter residues [9 ]. Only the 17-kDa proform and hCAP-18 were observed after immunoprecipitation with anti-LL-37 (Fig. 1B) . Thus, the 15- and 16-kDa processing forms observed in Figure 1A seem to represent the cathelin-like propeptide resulting from release of LL-37. This was also supported by experiments with RBL cells transfected with the cathelin sequence alone lacking the sequence for the antibacterial peptide. Thus, results from pulse-chase radiolabeling experiments (data not shown) demonstrated processing from a 14-kDa form to a 15-kDa form similar to the initial processing observed for the larger presumed proform into full-length hCAP-18 as shown in Figure 1A . These data indicated processing and secretion of the cathelin domain not to be dependent on the presence of the antibacterial peptide.



View larger version (34K):
[in this window]
[in a new window]
  		Figure 1. Expression of hCAP-18 in RBL cells. Cells transfected with cDNA of hCAP-18 were incubated for 30 min with [35S]methionine/[35S]cysteine (A and D) or [14C]leucine (B), followed by chase of the label for indicated time periods. (D) As indicated, NH4Cl (10 mM) or chloroquine (1 µM) was present during starvation, labeling, and chase. [14C]Leucine was used to get radiolabeling of LL-37 that lacks methionine/cysteine residues. At depicted time points, cells were removed and after lysis, were subjected to immunoprecipitation with anti-hCAP-18 (A) or anti-LL-37 (B and D). In addition, hCAP-18 was precipitated from the incubation medium at each chase time point. The immunoprecipitates were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) followed by fluorography. The fluorograms were exposed for 7 days (B) or 9 days (D). (C) Whole cell lysates of RBL/wild (wild) or RBL/hCAP-18 (hCAP-18) were subjected to Western blotting using anti-hCAP-18 or anti-LL-37 antibodies. For immunoprecipitation, the antibodies have the following specificity: Anti-LL-37 detects 17-kDa proform and mature 18-kDa hCAP-18. Anti-hCAP-18 detects the 17-kDa proform, mature 18-kDa hCAP-18, and the 15- and 16-kDa cathelin-processing forms. In addition, anti-LL-37 detects LL-37 by Western blotting but not when used in immunoprecipitation of hCAP-18-transfected cells.

 
Notably, LL-37 released from hCAP-18 could not be visualized by immunoprecipitation, indicating that it was degraded instantly after cleavage or lost during the experimental procedures. Therefore, we also performed Western blotting of cell lysates. Indeed, it was now possible by use of anti-LL-37 antibody, but not anti-hCAP-18 antibody, to visualize a protein in hCAP-18-transfected cells that corresponded to LL-37 (Fig. 1C) , indicating that LL-37 was lost during the immunoprecipitation. In conclusion, as judged by immunoprecipitation results, the anti-hCAP-18 polyclonal antibody detected the 17-kDa proform, hCAP-18, and the cathelin-like processing forms. Moreover, the anti-LL-37 polyclonal antibody detected 17-kDa proform and hCAP-18 but not cathelin-like processing forms of hCAP-18-transfected cells (Fig. 1C) . However, the anti-LL-37 antibody detected LL-37 by Western blotting. Accordingly, it seems that hCAP-18 is prematurely cleaved in RBL granules, giving rise to cathelin-like forms as well as to the antibiotic LL-37 peptide. However, we do not know whether LL-37 generated corresponds exactly to LL-37 generated normally because we have not determined the cleavage site in the former case.

To determine if the processing took place in a lysosomal compartment, cells were incubated with NH4Cl or chloroquine, thus blocking lysosomal proteolysis by increasing the pH. Results from pulse-chase labeling experiments carried out with either agent and using anti-LL-37 for immunoprecipitation showed a slight protection against proteolysis of hCAP-18 (Fig. 1D) , indicating that degradation may take place in a lysosomal/granule compartment. The constitutive secretion was not affected by either agent.

The promyelocytic MPRO cell line was also stably transfected with hCAP-18 cDNA. MPRO can be induced to differentiate into neutrophils with synthesis of specific granule transcripts by supraphysiological concentrations of ATRA [24 , 25 ]. hCAP-18 and its 17-kDa proform were observed after biosynthetic radiolabeling (Fig. 2 , top panel). Only hCAP-18, which dominated during chase of the radiolabel, was secreted. In contrast to RBL cells, only small amounts of cathelin-like processing forms were observed in MPRO cells, indicating less premature processing in MPRO granules than in RBL granules (compare with Fig. 1A ). After induction of differentiation with ATRA toward neutrophils, MPRO cells showed a slightly different processing of hCAP-18 in this experiment detected with anti-LL-37, which also detects hCAP-18. The conversion of the 17-kDa proform into hCAP-18 was slower, and secretion of proform was higher, but generation of visible LL-37 could not be observed (Fig. 2 , lower panel); the anti-LL-37 antibody is not able to detect LL-37 by immunoprecipitation (see below).



View larger version (42K):
[in this window]
[in a new window]
  		Figure 2. Expression of hCAP-18 in MPRO cells. Cells transfected with cDNA of hCAP-18 were incubated (top panel) or differentiated for 4 days with 10-5 M ATRA before the incubation (bottom panel) with [14C]leucine for 30 min, followed by chase of the label for indicated time periods. At depicted time points, 20 x 106 cells were removed and after lysis, were subjected to immunoprecipitation with anti-hCAP-18 or anti-LL-37. In addition, hCAP-18 was precipitated from the incubation medium at each chase time. The immunoprecipitates were analyzed as described in the legend to Figure 1 . The fluorograms were exposed for 29 and 36 days, respectively.

 
hCAP-18 is targeted to the cytoplasmic granules of RBL and MPRO cells
To investigate if hCAP-18 was translocated to the cytoplasmic granules of RBL cells, subcellular fractionation was performed followed by immunoprecipitation and subsequent Western blot, both performed with anti-hCAP-18. hCAP-18 and 17-kDa proform were observed in all fractions, and the cathelin-like processing forms were mainly visible in the most heavy fractions (fraction 1–2) corresponding to dense cytoplasmic organelles (Fig. 3 ); some processing forms were also seen in the cytosol (fraction 9) as a result of leakage from organelles into the cytosol during the fractionation procedure. Thus, hCAP-18 was targeted to the dense organelles of RBL followed by cleavage and release of cathelin-like processing forms. The release of LL-37, which is not detectable with the antibody to hCAP-18 used, does indeed occur as shown above by results from Western blotting using the antibody to LL-37 (Fig. 1C) .



View larger version (24K):
[in this window]
[in a new window]
  		Figure 3. Targeting hCAP-18 to dense cytoplasmic organelles in RBL cells. Cells (100x106) expressing hCAP-18 were subjected to homogenization, followed by subcellular fractionation of the postnuclear supernatant by centrifugation in Percoll with subsequent collection of nine subcellular fractions, with fraction no. 9 containing all cytosol. The fractions were lysed, subjected to immunoprecipitation with anti-hCAP-18, and analyzed by Western blot with anti-hCAP-18. Peak activities of ß-hexosaminidase, fractions 1–2, and galactosyl transferase, fractions 5–8, indicate the positions of lysosomes and Golgi elements, respectively.

 
We also examined whether hCAP-18 was targeted for storage in dense organelles of MPRO cells. Consequently, we performed pulse-chase radiolabeling experiments followed by subcellular fractionation. After 30 min of biosynthetic radiolabeling, newly synthesized mature hCAP-18 and 17-kDa proform dominated and were concentrated to light fractions corresponding to endoplasmic reticulum and Golgi, and only trace amounts were observed in dense organelles corresponding to granules (Fig. 4A ). After 3 h of chase of label, hCAP-18 was visible together with cathelin-like processing forms, both in heavy fractions (Fig. 4A , fractions 1+2) and in light fractions (Fig. 4A , fractions 7+8), suggesting that hCAP-18 may be cleaved in pregranule and granule structures. A similar pattern, but with much less cleavage product, was observed in cells incubated for 3 days with ATRA in order to induce differentiation toward neutrophils (Fig. 4B) . These results are consistent with those in Figure 2 , indicating less efficient sorting in more mature cells.



View larger version (16K):
[in this window]
[in a new window]
  		Figure 4. Targeting hCAP-18 to dense cytoplasmic organelles in MPRO cells. Cells expressing hCAP-18, undifferentiated (A) or differentiated for 3 days with 10-5 M ATRA (B), were incubated with [35S]methionine/[35S]cysteine for 30 min followed by chase of the label for 3 h. At depicted time periods, 100 x 106 cells were withdrawn and subjected to homogenization followed by subcellular fractionation, as described in the legend to Figure 2 , before the fractions were combined as indicated and immunoprecipitated with anti-hCAP-18. The immunoprecipitates were analyzed by SDS-PAGE followed by fluorography. The fluorograms were exposed for 8 weeks.

 
To confirm the targeting of hCAP-18 for storage in cytoplasmic granules, we performed immunoelectron microscopy with double-immunogold labeling to verify colocalization of hCAP-18 and known constituents of the granules of RBL cells. hCAP-18 was visible in multivesicular bodies as well as in TGN (Fig. 5A ). Multivesicular bodies mature as prelysosomal compartments [34 ] and therefore correspond to the abnormal granules of RBL cells. hCAP-18 colocalized with rat lgp120 in multivesicular bodies (Fig. 5B) . lgp120 Corresponds to hLAMP-1 and mLAMP-1 in humans and mice, respectively, indicating involvement of the endosomal/lysosomal pathway [35 ]. hCAP-18 was located in the interior of the multivesicular bodies, and lgp 120 was along its outer membrane (Fig. 5B) . hCAP-18 also colocalized with RMCP-II, the major constituent of the granules of RBL cells [22 ], in small electron-dense granules (Fig. 5C) . RMCP-II and lgp 120 colocalized in small electron-dense granules (Fig. 5D) . The amount of labeled hCAP-18 was larger in the multivesicular bodies than in the electron-dense granules (compare Fig. 5B and 5C ) compatible with instability of hCAP-18 in the granules of RBL cells. In conclusion, the secondary granule protein hCAP-18 was targeted to multivesicular bodies and cytoplasmic granules of RBL cells.



View larger version (182K):
[in this window]
[in a new window]
  		Figure 5. Colocalization of hCAP-18, lgp 120, and RMCP. (A and B) Ultrathin cryosections from RBL cells expressing hCAP-18 were double-labeled with rabbit anti-lgp 120 followed by protein A gold (10 nm) and with rabbit anti-hCAP-18 followed by protein A gold (15 nm). (C) Cells were double labeled with mouse anti-RMCP followed by rabbit anti-mouse and protein A gold (10 nm) and with rabbit anti-hCAP-18 followed by protein A gold (15 nm). (D) Double labeling was performed with rabbit anti-lgp 120 followed by protein A gold (10 nm) and with mouse anti-RMCP followed by rabbit anti-mouse and protein A gold (15 nm). (A) An area of a cell is shown with granules highly labeled for hCAP-18; also the TGN is labeled. (B) A higher magnification of the marked granule in A (*), and labeling is seen for lgp 120 on the membrane and for hCAP-18 on the matrix. (C) A granule double labeled for hCAP-18 and RMCP on the matrix, and (D), a granule is shown double labeled for lgp 120 on the membrane and RMCP on the matrix. Original bar, 200 nm.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
In the present investigation, hCAP-18, normally stored in specific granules of neutrophils, was expressed constitutively in the hematopoietic cell lines RBL and MPRO, which do not normally manufacture hCAP-18 or specific granules in which hCAP-18 resides. In these cells, constitutively expressed hCAP-18 was instead found to be sorted for storage in lysosome-related, cytoplasmic organelles, a class of organelles related to azurophil granules of neutrophils but normally lacking hCAP-18. We demonstrated as well, especially in RBL cells, that hCAP-18 was subject to processing in the lysosome-related organelles, resulting in generation of the antibiotic peptide LL-37, which normally is generated by proteolytic cleavage only after extracellular release of the hCAP-18 that is stored in specific neutrophil granules. Our results shed light on several aspects of myeloid cell biology, e.g., retrieval from constitutive secretion, sorting for storage, and stability during storage in granules, discussed below.

The composition of neutrophil granules is governed by coordination of expression of the genes for the granule proteins, and specific sorting mechanisms for targeting to different granule subtypes have not yet been identified [3 ]. Conversely, retrieval from the secretory pathway is necessary to allow targeting for granule storage. hCAP-18 was retrieved for storage even when expressed outside its normal biosynthetic window, here accomplished by widening the window through constitutive gene expression. We demonstrated previously that exogenous nonmyeloid, normally secretory proteins can be retained and are acceptable for storage in lysosome-related organelles [29 ]. Consequently, retention for storage may be a myeloid-specific property, allowing proteins with a compatible conformation to be sorted. However, not all soluble proteins delivered to the Golgi are sorted for storage in myeloid cells [36 ], suggesting the existence of conformation-based quality control for sorting. In contrast to endocrine and exocrine cells, many myeloid cells use the endosomal pathway for granule formation, a pathway that was involved in targeting hCAP-18, as judged by the results from immunogold labeling in RBL cells. Thus, hCAP-18 colocalized with lysosomal membrane markers in multivesicular bodies and small electron-dense cytoplasmic granules. Another specific granule protein, NGAL, has been shown to be targeted to azurophil-like granules when constitutively expressed in leukemic HL-60 cells, again emphasizing targeting mechanisms that are not necessarily protein-specific [20 ]. Moreover, HL-60 cells induced to mature into neutrophils did not retain newly synthesized NGAL, but released it to the exterior through constitutive secretion coupled to an inability of maturing HL-60 cells to form specific granules [37 ]. Similarly, induction of differentiation of MPRO cells resulted in augmented secretion of hCAP-18 in transfected cells. Accordingly, even if these cells have been shown to up-regulate transcripts for specific granule proteins such as lactoferrin and gelatinase during differentiation [25 ], the retention of constitutively expressed hCAP-18 diminished during maturation. This may result from down-regulation of the sorting machinery with lack of specific granule formation, despite gene expression for secondary granule proteins.

Lysosome-like azurophil granules may be proteolytically active at an early stage of formation in neutrophil precursors, as judged by their ability to process proforms of granule proteins to mature forms [2 ]. This has also been demonstrated for lysosome-related organelles of RBL cells in which proteolytic processing into mature granule proteins was observed as a post-sorting event [2 ]. The fully processed azurophil granule proteins are relatively stable in this proteolytic environment. However, in contrast to lack of processing in specific granules (the normal destination for hCAP-18), targeting to lysosome-related organelles of the myeloid cell lines resulted in processing with premature generation of LL-37, judging by our results from immunoprecipitation using antibodies with varying specificity. On the basis of antibody specificity, it is also concluded that the approximately 15-kDa processing forms observed in granules represent cathelin-like propeptides. The normal biosynthetic window of hCAP-18 in neutrophil precursors prevents targeting to azurophil granules that are formed prior to specific granules. It may be necessary to separate hCAP-18 from serine proteases of azurophil granules to prevent premature proteolytic release of its antibacterial activity (LL-37) and degradation. hCAP-18 is susceptible to cleavage by elastase, cathepsin G, and proteinase 3, normally stored in azurophil granules of neutrophils. However, proteinase 3 was shown to be responsible for the cleavage of hCAP-18 after exocytosis, although all the proteases may be released during degranulation [12 ].

We conclude that a specific granule protein, hCAP-18, can be targeted as a holoprotein for storage in lysosome-related organelles when constitutively expressed in myeloid cell lines, indicating the existence of cell-specific retention mechanisms for intracellular storage. Moreover, the mistargeting to lysosome-related organelles can lead to premature release of the antibiotic peptide LL-37 in the proteolytic environment of these organelles.


   ACKNOWLEDGEMENTS
 
This work was supported by the Swedish Cancer Foundation, funds of the Lund University Hospital, and the Alfred Österlund Foundation. The expert technical assistence of A-M. Persson is greatly appreciated, and we thank Hans Janssen and Nico Ong for their expert technical assistance with electron miscroscopy.

Received November 21, 2001; revised January 8, 2002; accepted January 25, 2002.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Levy, O. (1996) Antibiotic proteins of polymorphonuclear leukocytes Eur. J. Haematol. 56,263-277[Medline]
  2. Gullberg, U., Bengtsson, N., Bülow, E., Garwicz, D., Lindmark, A., Olsson, I. (1999) Processing and targeting of granule proteins in human neutrophils J. Immunol. Methods 232,201-210[Medline]
  3. Borregaard, N., Cowland, J. B. (1997) Granules of the human neutrophilic polymorphonuclear leukocyte Blood 89,3503-3521[Free Full Text]
  4. Strömberg, K., Persson, A.-M., Olsson, I. (1985) The processing and intracellular transport of myeloperoxidase. Modulation by lysosomotropic agents and monensin Eur. J. Cell Biol. 39,424-431
  5. Weiss, J., Olsson, I. (1987) Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils Blood 69,652-659[Abstract/Free Full Text]
  6. Ganz, T., Selsted, M. E., Szklarek, D., Harwig, S. S., Daher, K., Bainton, D. F., Lehrer, R. I. (1985) Defensins. Natural peptide antibiotics of human neutrophils J. Clin. Invest. 76,1427-1435
  7. Egesten, A., Breton-Gorius, J., Guichard, J., Gullberg, U., Olsson, I. (1994) The heterogeneity of azurophil granules in neutrophil promyelocytes: immunogold localization of myeloperoxidase, cathepsin G, elastase, proteinase 3, and bactericidal/permeability increasing protein Blood 83,2985-2994[Abstract/Free Full Text]
  8. Larrick, J. W., Hirata, M., Balint, R. F., Lee, J., Zhong, J., Wright, S. C. (1995) Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein Infect. Immun. 63,1291-1297[Abstract]
  9. Agerberth, B., Gunne, H., Odeberg, J., Kogner, P., Boman, H. G., Gudmundsson, G. H. (1995) FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis Proc. Natl. Acad. Sci. USA 92,195-199[Abstract/Free Full Text]
  10. Cowland, J. B., Johnsen, A. H., Borregaard, N. (1995) hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules FEBS Lett. 368,173-176[Medline]
  11. Gudmundsson, G. H., Agerberth, B., Odeberg, J., Bergman, T., Olsson, B., Salcedo, R. (1996) The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes Eur. J. Biochem. 238,325-332[Medline]
  12. Sørensen, O. E., Follin, P., Johnsen, A. H., Calafat, J., Tjabringa, G. S., Hiemstra, P. S., Borregaard, N. (2001) Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3 Blood 97,3951-3959[Abstract/Free Full Text]
  13. Yang, D., Chen, Q., Schmidt, A. P., Anderson, G. M., Wang, J. M., Wooters, J., Oppenheim, J. J., Chertov, O. (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells J. Exp. Med. 192,1069-1074[Abstract/Free Full Text]
  14. Gullberg, U., Andersson, E., Garwicz, D., Lindmark, A., Olsson, I. (1997) Biosynthesis, processing and sorting of neutrophil proteins: insight into neutrophil granule development Eur. J. Haematol. 58,137-153[Medline]
  15. Dell’Angelica, E. C., Mullins, C., Caplan, S., Bonifacino, J. S. (2000) Lysosome-related organelles FASEB J. 14,1265-1278[Abstract/Free Full Text]
  16. Tooze, S. A., Martens, G. J., Huttner, W. B. (2001) Secretory granule biogenesis: rafting to the SNARE Trends Cell Biol. 11,116-122[Medline]
  17. Olsson, I., Lantz, M., Persson, A.-M., Arnljots, K. (1988) Biosynthesis and processing of lactoferrin in bone marrow cells, a comparison with processing of myeloperoxidase Blood 71,441-447[Abstract/Free Full Text]
  18. Dahlgren, C., Carlsson, S. R., Karlsson, A., Lundqvist, H., Sjölin, C. (1995) The lysosomal membrane glycoproteins Lamp-1 and Lamp-2 are present in mobilizable organelles, but are absent from the azurophil granules of human neutrophils Biochem. J. 311,667-674
  19. Cieutat, A. M., Lobel, P., August, J. T., Kjeldsen, L., Sengeløv, H., Borregaard, N., Bainton, D. F. (1998) Azurophilic granules of human neutrophilic leukocytes are deficient in lysosome-associated membrane proteins but retain the mannose 6-phosphate recognition marker Blood 91,1044-1058[Abstract/Free Full Text]
  20. Le Cabec, V., Cowland, J. B., Calafat, J., Borregaard, N. (1996) Targeting of proteins to granule subsets is determined by timing and not by sorting: the specific granule protein NGAL is localized to azurophil granules when expressed in HL-60 cells Proc. Natl. Acad. Sci. USA 93,6454-6457[Abstract/Free Full Text]
  21. Kozak, M. (1987) An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs Nucleic Acids Res. 15,8125-8148[Abstract/Free Full Text]
  22. Seldin, D. C., Adelman, S., Austen, K. F., Stevens, R. L., Hein, A., Caulfield, J. P., Woodbury, R. G. (1985) Homology of the rat basophilic leukemia cell and the rat mucosal mast cell Proc. Natl. Acad. Sci. USA 82,3871-3875[Abstract/Free Full Text]
  23. Garwicz, D., Lindmark, A., Gullberg, U. (1995) Human cathepsin G lacking functional glycosylation site is proteolytically processed and targeted for storage in granules after transfection to the rat basophilic/mast cell line RBL or the murine myeloid cell line 32D J. Biol. Chem. 270,28413-28418[Abstract/Free Full Text]
  24. Tsai, S., Collins, S. J. (1993) A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage Proc. Natl. Acad. Sci. USA 90,7153-7157[Abstract/Free Full Text]
  25. Lawson, N. D., Krause, D. S., Berliner, N. (1998) Normal neutrophil differentiation and secondary granule gene expression in the EML and MPRO cell lines Exp. Hematol. 26,1178-1185[Medline]
  26. Gullberg, U., Lindmark, A., Nilsson, E., Persson, A.-M., Olsson, I. (1994) Processing of human cathepsin G after transfection to the rat basophilic/mast cell tumor line RBL J. Biol. Chem. 269,25219-25225[Abstract/Free Full Text]
  27. Hultberg, B., Lindsten, J., Sjöblad, S. (1976) Molecular forms and activities of glycosidases in cultures of amniotic-fluid cells Biochem. J. 155,599-605[Medline]
  28. Bretz, R., Staubli, W. (1977) Detergent influence on rat-liver galactosyltransferase activities towards different acceptors Eur. J. Biochem. 77,181-192[Medline]
  29. Bülow, E., Gullberg, U., Olsson, I. (2000) Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein J. Leukoc. Biol. 68,669-678[Abstract/Free Full Text]
  30. Calafat, J., Janssen, H., Ståhle-Bäckdahl, M., Zuurbier, A. E., Knol, E. F., Egesten, A. (1997) Human monocytes and neutrophils store transforming growth factor-alpha in a subpopulation of cytoplasmic granules Blood 90,1255-1266[Abstract/Free Full Text]
  31. Liou, W., Geuze, H. J., Slot, J. W. (1996) Improving structural integrity of cryosections for immunogold labeling Histochem. Cell Biol. 106,41-58[Medline]
  32. Slot, J. W., Geuze, H. J., Gigengack, S., Lienhard, G. E., James, D. E. (1991) Immuno-localization of the insulin regulatable glucose transporter in brown adipose tissue of the rat J. Cell Biol. 113,123-135[Abstract/Free Full Text]
  33. Sørensen, O., Arnljots, K., Cowland, J. B., Bainton, D. F., Borregaard, N. (1997) The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils Blood 90,2796-2803[Abstract/Free Full Text]
  34. Berger, M., Wetzler, E., August, J. T., Tartakoff, A. M. (1994) Internalization of type 1 complement receptors and de novo multivesicular body formation during chemoattractant-induced endocytosis in human neutrophils J. Clin. Invest. 94,1113-1125
  35. Granger, B. L., Green, S. A., Gabel, C. A., Howe, C. L., Mellman, I., Helenius, A. (1990) Characterization and cloning of lgp110, a lysosomal membrane glycoprotein from mouse and rat cells J. Biol. Chem. 265,12036-12043[Abstract/Free Full Text]
  36. Andersson, E., Hellman, L., Gullberg, U., Olsson, I. (1998) The role of the propeptide for processing and sorting of human myeloperoxidase J. Biol. Chem. 273,4747-4753[Abstract/Free Full Text]
  37. Le Cabec, V., Calafat, J., Borregaard, N. (1997) Sorting of the specific granule protein, NGAL, during granulocytic maturation of HL-60 cells Blood 89,2113-2121[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
J. Stie, A. V. Jesaitis, C. I. Lord, J. M. Gripentrog, R. M. Taylor, J. B. Burritt, and A. J. Jesaitis
Localization of hCAP-18 on the surface of chemoattractant-stimulated human granulocytes: analysis using two novel hCAP-18-specific monoclonal antibodies
J. Leukoc. Biol., July 1, 2007; 82(1): 161 - 172.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bülow, E.
Right arrow Articles by Olsson, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bülow, E.
Right arrow Articles by Olsson, I.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS